Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients

Lancet. 1995 Apr 8;345(8954):894-6. doi: 10.1016/s0140-6736(95)90011-x.

Abstract

Reported side-effects of tacrolimus, a potent immunosuppressive agent, have not included cardiotoxicity. We describe 5 consecutive paediatric transplant recipients (3 small bowel with or without liver and 2 liver) who received tacrolimus. 2 developed congestive heart failure and hypertrophic obstructive cardiomyopathy which resolved after changing to cyclosporin. In the other 3 patients the cardiomyopathy regressed or improved with a lower dose of tacrolimus or after stopping the drug.

MeSH terms

  • Blood Pressure / drug effects
  • Cardiomyopathy, Hypertrophic / chemically induced*
  • Child, Preschool
  • Colon / transplantation
  • Echocardiography
  • Female
  • Heart Failure / chemically induced
  • Humans
  • Infant
  • Liver Transplantation
  • Male
  • Postoperative Complications / chemically induced*
  • Tacrolimus / adverse effects*
  • Tacrolimus / blood

Substances

  • Tacrolimus